AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (214 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Corrigendum | Open Access

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401]

Uttpal Ananda, Abhijit Deyb,1, Arvind K. Singh Chandelc,1, Rupa Sanyald, Amarnath Mishrae( ), Devendra Kumar Pandeyf, Valentina De Falcog, Arun Upadhyayh, Ramesh Kandimallai,j, Anupama Chaudharyk, Jaspreet Kaur Dhanjall, Saikat Dewanjeem, Jayalakshmi Vallamkondun, José M. Pérez de la Lastrao( )
Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
Department of Life Sciences, Presidency University, Kolkata, West Bengal 700073, India
Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
Department of Botany, Bhairab Ganguly College (affiliated to West Bengal State University), Kolkata, West Bengal 700056, India
Faculty of Science and Technology, Amity Institute of Forensic Sciences, Amity University Uttar Pradesh, Noida 201313, India
Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, Punjab 144411, India
Institute of Endocrinology and Experimental Oncology (IEOS), National Research Council (CNR), Department of Molecular Medicine and Medical Biotechnology (DMMBM), University of Naples Federico II, Naples 80131, Italy
Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Bandar Sindari, Kishangarh Ajmer, Rajasthan 305817, India
CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana 500007, India
Department of Biochemistry, Kakatiya Medical College, Warangal, Telangana 506007, India
Orinin-BioSystems, LE-52, Lotus Road 4, CHD City, Karnal, Haryana 132001, India
Department of Computational Biology, Indraprastha Institute of Information Technology Delhi (IIIT-D), Okhla Industrial Estate, Phase III, New Delhi 110020, India
Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India
Department of Physics, National Institute of Technology-Warangal, Warangal, Telangana 506004, India
Biotechnology of Macromolecules Research Group, Instituto de Productos Naturales y Agrobiología, IPNA-CSIC, San Cristóbal de La Laguna 38206, Tenerife, Spain

Peer review under responsibility of Chongqing Medical University.

1 Equal contribution.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Genes & Diseases
Volume 11 Issue 4,
July 2024
Article number: 101211
DOI: 10.1016/j.gendis.2024.101211

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Anand U, Dey A, Singh Chandel AK, et al. Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases 10 (2023) 1367–1401]. Genes & Diseases, 2024, 11(4): 101211. https://doi.org/10.1016/j.gendis.2024.101211

681

Views

10

Downloads

21

Crossref

12

Web of Science

21

Scopus

0

CSCD
Published: 20 January 2024
© 2024 The Authors.